Cite
HARVARD Citation
Fujiwara, K. et al. (n.d.). 265TiPKEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer. Annals of oncology. p. . [Online].